Professor Mike Osborn studied medicine at Guy's & St Thomas' Hospitals, London, qualifying in 1995. He became a member of the Royal College of Surgeons in 2000 and a Fellow of the Royal College of Pathologists in 2004.

Currently he works as a Consultant Histopathologist for North West London Pathology at Imperial College Healthcare NHS Trust, London, where he is clinical lead. His working time is divided between post mortems, diagnostic gastrointestinal histopathology, bowel cancer screening and teaching. He runs a BSc in Humanities, Philosophy & Law at Imperial College, London.

Evangelos has a background in economics and finance and prior to joining Sonic Healthcare had a career in investment banking with J.P.Morgan´s healthcare investment banking team in New York, London and Sydney.

He is married with two children and is currently based in Berlin, Germany. Evangelos also serves on the Boards of the German-Australian Business Council and the Accredited Medical Laboratories Association and is a Trustee of the World Doctors Orchestra.

Martha is Senior Lecturer at University of Surrey School of Veterinary Medicine and Head of Department of Veterinary Epidemiology and Public Health.

Martha studied at University of Cambridge and University College London. She has extensive postdoctoral experience from UK and overseas institutions. She is PI of the MRC-funded ZooTRIP project investigating zoonotic transmission of intestinal worms in the Philippines and a consortium member of the One Health EJP projects TOXOSOURCES and PARADISE.

https://www.surrey.ac.uk/people/martha-betson

https://www.surrey.ac.uk/news/interview-dr-martha-betson

Pikka works at the Statens Serum Institut in Denmark. She is a veterinarian and did her PhD on Toxoplasma gondii at University of Helsinki, where she continues as Adjunct Professor in zoonotic parasitology. She is the 1st Vice-President of the World Federation of Parasitologists and President of the Scandinavian-Baltic Society for Parasitology.

In the One Health EJP, she is the Project Leader of TOXOSOURCES, consortium member of projects PARADISE, MEME and OH-Harmony-CAP, as well as the Deputy Leader of the WP3 (Joint Research Projects) and Collaborator of WP5 (Science to policy translation).

Twitter: @PikkaJokelainen

Professor Tahir Pillay is full Professor and Head of the Department of Chemical Pathology and overall Pathology Head, University of Pretoria & National Health Laboratory Service(NHLS),  Honorary Professor of Chemical Pathology, University of Cape Town (UCT) in South Africa.  He is immediate past President of the South African Association for Clinical Biochemistry and Laboratory  Medicine (SAACB). He is  also Chair of the Communications and Publication Division(CPD) of the International Federation of  Clinical Chemistry & Laboratory Medicine (IFCC), the first person from Africa to lead a division of the IFCC  in its 75 year history. He was previously head of Chemical Pathology at UCT and Deputy Vice Chancellor at the University of KwaZulu-Natal; Deputy Director, Institute of Cell Signalling, University of Nottingham, UK.  He currently holds the highest research ranking of any chemical pathologist in South Africa by the National Research Foundation, South Africa and one of  only  two full professors of chemical pathology in South Africa. He is a board member of the World Association of Pathology & Laboratory Medicine (WASPALM) and the Medical Research Council(MRC), South Africa. He is also one of only  two pathologists in South Africa who is an elected member of the Academy of Science of South Africa.

He has previously served on the International committee of the Royal College of Pathologists as country advisor for South Africa. He has served on the Publications Core Committee of the American Association of Clinical Chemistry (now the Association of Diagnostic Laboratory Medicine), the first member of an  AACC committee  from outside North America. Nationally, he has served as Ministerial appointee to the Health Professions Council of South Africa (HPCSA) Medical and Dental Board (MDB); Council member of the College of Pathologists, SA and Senate member of the Colleges of Medicine, SA; member of the Postgraduate Education and Training committee, HPCSA MDB; chair of the Curriculum Committee and Standard Generating Body of the HPCSA-MDB; member of the Clinical Chemistry Expert committee, National Health Laboratory Service. He is also a member of the WHO Expert panel on Point-of-care testing (2022).

He has also served as Editor-in-Chief of the Journal of Clinical Pathology for two terms. Professor Pillay has an MBChB cum laude from the University of Natal and  a PhD in biochemistry from the University of Cambridge. He completed his postgraduate specialist training at Imperial College  and postdoctoral training in molecular and cellular endocrinology at University of California San Diego. He is a Fellow of the Royal College of Pathologists, London and the College of Pathologists, South Africa. Professor Pillay’s research publications spans molecular cell biology of insulin signalling and insulin resistance, molecular modelling of ligand-receptor complexes and development of new diagnostic probes for laboratory diagnostics and toxicology using recombinant DNA technology. He is pioneering the increased application of single domain antibodies/nanobodies in pathology and laboratory medicine and forensic toxicology. His group received the first prize in the 2020 GAP Innovation award run by Emory University and TIA  for the development of a nanobody based  test for Covid-19.He is also a chapter contributor to the two  most prestigious textbooks in Clinical Chemistry and Lab Medicine – Tietz Textbook of Clinical Chemistry, 7^th ed (published Aug 2022) and Tietz Fundamentals of Clinical Chemistry (published in 2023).  He is also sole author of two 4-dimensional electronic books in laboratory medicine (“Practical Clinical Chemistry:core concepts”; “Interactive mathematics for laboratory medicine”) that have been released in 52 countries.

In 2023 and 2024, he has been listed in the Pathologist magazine  Power List as one of the Top 100 most influential people in pathology – specifically, as one of the Top 20 Champions for Change. In his spare time, he produces deep house and electronic dance music through his record label, DJ Kempat.

Until recently, he was also a Clinical Director of a large specialty grouping. He is lead for NE and Yorkshire Haemoglobinopathy Network and has held posts as the Chair of the Laboratory Subgroup of the NHS Sickle and Thalassaemia screening programme and as a lead clinician for the UK Haemoglobinopathy peer review programme. He is currently Vice President of the British Society of Haematology.